Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_provenance.
- NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_assertion description "[Similarly, the treatment of primary MALT lymphoma cells with the ABL inhibitors imatinib and dasatinib prevented tumor cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_provenance.
- NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_assertion evidence source_evidence_literature NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_provenance.
- NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_assertion SIO_000772 21454413 NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_provenance.
- NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_assertion wasDerivedFrom befree-2016 NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_provenance.
- NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_assertion wasGeneratedBy ECO_0000203 NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP883622.RA077E0KBcAyY_KfCy8J2c49UY3oBtwWpKUk8XZTFEtqQ130_provenance.